Env and platform designs to improve antibody responses
Wednesday, February 3, 2021
•
OA15
•
5:30 PM
>
6:30 PM
•
Env and platform designs to improve antibody responses
•
Live channel 1
5:30 PM
•
OA15.01
•
Heterologous vaccination with DNA and two different poxvirus vectors, expressing HIV-1 envelope on the surface of Gag virus-like particles, elicit autologous Tier 2 neutralising antibodies
See abstract
5:38 PM
•
OA15.02
•
In vitro and in vivo analyses of HIV-1 clade C Envelope trimers highlight optimal antigenic profiles of novel HIV-1 Env-based vaccine candidates
See abstract
5:46 PM
•
OA15.03
•
Novel trimer-only (TO) producing HIV-1 envelope glycoprotein constructs for inducing broadly neutralizing antibody responses by genetic vaccination
See abstract
5:54 PM
•
OA15.04
•
Structural Basis of Neutralizing Antibodies Targeting the CD4-Binding Site and Fusion Peptide Elicited by Immunization with Heterologous HIV-1 Env in NHP
See abstract
6:02 PM
•
OA15.05LB
•
Cross-reactivity between HIV-1 bnAbs and parasite glycans
See abstract
6:10 PM
•
OA15.06
•
Live Q&A
See abstract
|